Iman Jilani is a Sr Director and Head of Translational Biomarkers at Arrowhead Pharmaceuticals, with over 30 years of experience in global pharmaceutical and biotech sectors. Previously, Iman served as the Sr Director and Head of the Oncology Biomarker Clinical Assay Group at Pfizer, where they led biomarker development and operational initiatives. Iman is recognized for their expertise in regulatory compliance, CRO management, and clinical trial data management, having overseen significant cost savings and contributed to the development of several oncology drugs and biomarkers. Iman is currently focused on advancing personalized cancer therapies through collaborations with various stakeholders and clinical teams.
This person is not in any teams
This person is not in any offices